UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549

               STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

                                  FORM 4

[ ] Check this box if no longer                  OMB APROVAL
    subject to Section 16. Form 4 or             OMB NUMBER:  3235-0287
    Form 5 obligations may continue.             Expires: September 30, 1998
    See Instruction 1(b).                        Estimated average burden
                                                 hours per response........0.5

  Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
      Section 17(a) of the Public Utility Holding Company Act of 1935
          or Section 30(f) of the Investment Company Act of 1940

(Print or Type Responses)

1. Name and Address of Reporting Person*

    Husain                            M.                         Fazle
- -----------------------------------------------------------------------------
     (Last)                         (First)                      (Middle)

    1221 Avenue of the Americas
- -----------------------------------------------------------------------------
                                   (Street)

    New York                          NY                             10020
- -----------------------------------------------------------------------------
     (City)                         (State)                           (Zip)


2.   Issuer Name and Ticker or Trading Symbol

     Allscripts Healthcare Solutions, Inc. (MDRX)
- -----------------------------------------------------------------------------

3.   I.R.S. or Social Security Number of Reporting Person (Voluntary)


- -----------------------------------------------------------------------------


4.   Statement for Month/Year

     06/01
- -----------------------------------------------------------------------------


5.   If Amendment, Date of Original (Month/Day/Year)


- -----------------------------------------------------------------------------


6.   Relationship of Reporting Person(s) to Issuer   (Check all applicable)

     X Director                                          10% Owner
    ---                                               ---

       Officer (give title below)                        Other (specify below)
    ---                                               ---

- ----------------------------------------------------------------------------


7.   Individual or Joint/Group Filing (Check Applicable Line)

 X      Form filed by One Reporting Person
- ----

        Form filed by More than One Reporting Person
- ----


      Table I -- Non-Derivative Securities Acquired, Disposed of, or
                            Beneficially Owned


1.   Title of Security    2. Trans-  3. Trans-     4. Securities Acquired  5. Amount of Securities  6. Ownership      7. Nature of
     (Instr. 3)              action     action        (A) or Disposed of      Beneficially Owned       Form: Direct      Indirect
                             Date       Code          (D) (Instr. 3, 4        at End of Month          (D) or In-        Beneficial
                                        (Instr.8)     and 5)                  (Instr. 3 and 4)         direct (I)        Ownership
                             (Month/                                                                   (Instr. 4)        (Instr. 4)
                             Day/                         (A) or
                             Year)    Code    V    Amount   (D)    Price
- ------------------------- ---------   ----   ---   -------  --- ---------  --------------------     --------------    -------------
                                                                                              
Common Stock              06/15/01     J1         19,250    A       0               38,180                 D          through
                                                                                                                      participation

Common Stock                                                                     2,954,063                 I(2)       through
                                                                                                                      partnerships


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

                                                                          (Over)
                                                                 SEC 1474 (7-96)

FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of 2. Conversion or 3. Transaction Date 4. Transaction 5. Number of 6. Date Exercisable and Derivative Exercise Price (Month/Day/Year) Code Derivative Expiration Date Security of Derivative (Instr. 8) Securities (Month/Day/Year) (Instr. 3) Security Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) Date Expiration Code V (A) (D) Exercisable Date - ------------------------------------------------------------------------------------------------------------------------------------
1. Title of 7. Title and Amount of 8. Price of 9. Number of 10. Ownership 11. Nature of Derivative Underlying Securities Derivative Derivative Form of Indirect Security (Instr. 3 and 4) Security Securities Derivative Beneficial (Instr. 3) (Instr. 5) Beneficially Security: Ownership Amount Owned at End Direct (D) (Instr. 4) or of Month or Indirect Number (Instr. 4) (I) of (Instr. 4) Title Shares - ------------------------------------------------------------------------------------------------------------------------------------ Explanation of Responses: 1. The Reporting Person received 19,250 shares of Common Stock in a distribution-in-kind from Morgan Stanley Venture Partners III, L.L.C., the general partner (the "General Partner") of Morgan Stanley Venture Partners III, L.P., Morgan Stanley Venture Investors III, L.P., and The Morgan Stanley Venture Partners Entrepreneur Fund, L.P (collectively, the "Funds"). The General Partner had received the shares of Common Stock in distributions-in-kind from the Funds. 2. The Reporting Person is a managing member of the General Partner. The Reporting Person disclaims any beneficial ownership of any of the securities owned by the Funds except to the extent of his proportionate pecuniary interest in the General Partner. **Intentional misstatements or omissions of facts constitute Federal /s/ Debra Abramovitz July 9, 2001 Criminal Violations. ------------------------------- ----------------------- **Signature of Reporting Person Date Debra Abramovitz, Attorney-in- Fact for M. Fazle Husain Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. Page 2 SEC 1474 (7-96)